Looking to expand your partner network with leading companies like Merck Ventures? Consider joining Inpart's global network for free.
News and Trends 26 Aug 2022
Aktis Oncology raises millions in funding bringing total to $161M
Aktis Oncology announced yesterday (August 25) that it has raised a series A extension financing of $84 million bringing its total capital raised to date to $161 million. The Massachusetts-based company develops targeted alpha radiopharmaceuticals to treat a broad range of solid tumors. Aktis Oncology‘s investors The extension included participation from new health investors Cowen […]